Pain frequency decreased significantly ( P < @ ) in @ ( @ % ) , @ ( @ % ) , and @ ( @ % ) patients in the drotaverine group , at the end of @nd , @rd , and @th weeks , respectively , as compared with @ ( @ % ) , @ ( @ % ) , and @ ( @ % ) in the placebo group .